Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stroke-induced Immunodepression: Role in the Neurorehabilitation Setting

NCT05889169 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05889169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stroke-induced Immunodepression: Role in the Neurorehabilitation Setting
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Phase
Observational
Overall status
Completed
Start date
February 1, 2019
Completion date
September 30, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, lymphopenia, stroke